Status:
COMPLETED
Diffusion Tensor Imaging in Chronic Inflammatory Demyelinating Polyneuropathy (PIDC)
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)
CMT (Charcot Marie Tooth Disease)
Eligibility:
All Genders
18+ years
Brief Summary
The main purpose of this study is to assess the clinical feasibility of diffusion tensor imaging (DTI) for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). For thar p...
Detailed Description
Investigator will prospectively enroll 15 patients with CIDP followed in the Neurology Department of Clermont Ferrand University Hospital, who satisfy the Joint Task Force of the EFNS and PNS definite...
Eligibility Criteria
Inclusion
- \- For All patients: at least 18 years-old.
- For CMT1a group : CMT1 a should be proven by genetic testing
- For CIDP group: CIDP should satisfied the definite CIDP criteria of the Joint Task Force of the EFNS and PNS 1 (situations A and B according to the French CIDP work group2). They might have received steroids, immunoglobulin or immunosuppressive treatments
Exclusion
- For all groups: any neurological comorbidity, other causes of neuropathy or history of exposure to neurotoxic agents (the inclusion and exclusion criteria are detailed in supplemental data) allergies, renal failure, Pregnancy
Key Trial Info
Start Date :
November 18 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2015
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT03460951
Start Date
November 18 2013
End Date
December 31 2015
Last Update
March 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63003